Natural metabolites used in traditional Chinese medicine for cardiovascular diseases: pharmacological mechanisms, evidence, and future directions

Cardiovascular diseases (CVDs) remain the leading cause of death and disability worldwide, highlighting an urgent need for new treatments. Traditional Chinese Medicine (TCM) offers a rich repository of natural metabolites (flavonoids, alkaloids, saponins, etc.) that act on multiple targets to protect the heart and blood vessels. These compounds have demonstrated multiple cardioprotective effects, including anti-inflammatory, antioxidant, anti-atherosclerotic, and blood pressure–lowering activities. They work by reducing oxidative stress, dampening chronic inflammation, improving blood vessel function, correcting abnormal lipid levels, and mitigating cardiac fibrosis. Recent preclinical studies and clinical trials show that TCM-derived metabolites can improve cardiovascular health. For instance, the multi-herb formula Qili Qiangxin and the alkaloid berberine have improved heart failure symptoms and cardiac function in clinical trials when added to standard therapy. These examples underscore the clinical potential of TCM compounds. However, challenges like poor bioavailability, complex multi-component interactions, and lack of standardization still hinder their widespread use. To address these issues, researchers are exploring advanced drug delivery methods and better quality control with modern analytical tools. If these hurdles are overcome, TCM-derived therapies could be successfully integrated into mainstream cardiovascular care, offering a novel multi-target approach to combat CVDs.

• Publication year

  2025

• Venue

  Frontiers in Pharmacology

• Publication date

  2025-11-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.3389/fphar.2025.1656751PMID 41293245PMCID 12641511
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

  2025cited by this paper
• Effects of sodium tanshinone IIA sulfonate injection on pro-inflammatory cytokines, adhesion molecules and chemokines in Chinese patients with atherosclerosis and atherosclerotic cardiovascular disease: a meta-analysis of randomized controlled trials

  2025cited by this paper
• Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes

  2025cited by this paper
• Flavonoids and their role in oxidative stress, inflammation, and human diseases.

  2025cited by this paper
• Berberine improves cardiac insufficiency through AMPK/PGC-1α signaling-mediated mitochondrial homeostasis and apoptosis in HFpEF mice.

  2025cited by this paper
• Efficacy and safety of Tongxinluo capsules combined with conventional therapy for acute myocardial infarction: a systematic review and meta-analysis

  2025cited by this paper
• Drug Interaction Potential of Berberine Hydrochloride When Co-Administered with Tofacitinib and Filgotinib in Rats

  2025cited by this paper
• Berberine as a multi-target therapeutic agent for obesity: from pharmacological mechanisms to clinical evidence

  2025cited by this paper
• Protective effects of puerarin on metabolic diseases: Emphasis on the therapeutical effects and the underlying molecular mechanisms.

  2024cited by this paper
• Pharmacological mechanisms by which baicalin ameliorates cardiovascular disease

  2024cited by this paper
• The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial

  2024cited by this paper
• Berberine ameliorates vascular dysfunction by downregulating TMAO-endoplasmic reticulum stress pathway via gut microbiota in hypertension.

  2024cited by this paper
• The role of Chinese herbal medicine in the regulation of oxidative stress in treating hypertension: from therapeutics to mechanisms

  2024cited by this paper
• Pre-treatment with notoginsenoside R1 from Panax notoginseng protects against high-altitude-induced pulmonary edema by inhibiting pyroptosis through the NLRP3/caspase-1/GSDMD pathway.

  2024cited by this paper
• Palmatine protects against atherosclerosis by gut microbiota and phenylalanine metabolism.

  2024cited by this paper
• Traditional Chinese medication Qili qiangxin capsule protects against myocardial ischemia-reperfusion injury through suppressing autophagy via the Phosphoinositide 3-kinase/Protein kinase B/Forkhead box O3 axis.

  2024cited by this paper
• Associations Between Flavonoid Intake and Subclinical Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis

  2024cited by this paper
• Quercetin supplementation prevents kidney damage and improves long‐term prognosis in hypertensive patients

  2024cited by this paper
• The plant extract PNS mitigates atherosclerosis via promoting Nrf2‐mediated inhibition of ferroptosis through reducing USP2‐mediated Keap1 deubiquitination

  2024cited by this paper
• Comparative efficacy of eight oral Chinese patent medicines for dilated cardiomyopathy with heart failure: a Bayesian network meta-analysis

  2024cited by this paper
• Benefits of Puerarin on Metabolic Syndrome and Its Associated Cardiovascular Diseases in Rats Fed a High-Fat/High-Sucrose Diet

  2024cited by this paper
• Dietary supplements: clinical cholesterol-lowering efficacy and potential mechanisms of action

  2024cited by this paper
• Ginsenoside Rk1 improves endothelial function in diabetes through activating peroxisome proliferator-activated receptors.

  2024cited by this paper
• Current insights and future perspectives of flavonoids: A promising antihypertensive approach

  2024cited by this paper
• Thrombosis inhibited by Corydalis decumbens through regulating PI3K-Akt pathway.

  2024cited by this paper
• A systematic review and meta-analysis on sodium tanshinone IIA sulfonate injection for the adjunctive therapy of pulmonary heart disease

  2024cited by this paper
• The effects of citrus flavonoids supplementation on endothelial function: A systematic review and dose–response meta‐analysis of randomized clinical trials

  2024cited by this paper
• Nanodelivery system of traditional Chinese medicine bioactive compounds: Application in the treatment of prostate cancer.

  2024cited by this paper
• Neferine Pretreatment Attenuates Isoproterenol-Induced Cardiac Injury Through Modulation of Oxidative Stress, Inflammation, and Apoptosis in Rats

  2024cited by this paper
• Naringenin Inhibits Acid Sphingomyelinase-Mediated Membrane Raft Clustering to Reduce NADPH Oxidase Activation and Vascular Inflammation.

  2024cited by this paper
• Morusin Alleviates Aortic Valve Calcification by Inhibiting Valve Interstitial Cell Senescence Through Ccnd1/Trim25/Nrf2 Axis

  2024cited by this paper
• Matrine attenuating cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity through improved mitochondrial membrane potential and activation of mitochondrial respiratory chain Complex I pathway.

  2024cited by this paper
• Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial Infarction.

  2024cited by this paper
• Lycorine inhibits Ang II-induced heart remodeling and inflammation by suppressing the PI3K-AKT/NF-κB pathway.

  2024cited by this paper
• Compound Danshen Dripping Pill effectively alleviates cGAS-STING-triggered diseases by disrupting STING-TBK1 interaction.

  2024cited by this paper
• Salvia miltiorrhiza Bunge (Danshen) based nano-delivery systems for anticancer therapeutics.

  2024cited by this paper
• The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review

  2024cited by this paper
• Ginsenoside RH4 inhibits Ang II-induced myocardial remodeling by interfering with NFIL3.

  2024cited by this paper
• Palmatine alleviates cardiac fibrosis by inhibiting fibroblast activation through the STAT3 pathway.

  2024cited by this paper
• Baicalein ameliorated obesity-induced cardiac dysfunction by regulating the mitochondrial unfolded protein response through NRF2 signaling.

  2024cited by this paper
• Saponins as therapeutic candidates for atherosclerosis

  2024cited by this paper
• Ginsenoside Rd: A promising target for ischemia-reperfusion injury therapy (A mini review).

  2024cited by this paper
• Saponins as potential novel NLRP3 inflammasome inhibitors for inflammatory disorders

  2024cited by this paper
• Inflammation in atherosclerosis: pathophysiology and mechanisms

  2024cited by this paper
• Endothelial-derived exosomes: A novel therapeutic strategy for LPS-induced myocardial damage with anisodamine.

  2024cited by this paper
• Integration of network pharmacology and transcriptomics to explore the mechanism of isoliquiritigenin in treating heart failure induced by myocardial infarction.

  2024cited by this paper
• Anthocyanins as natural bioactives with anti-hypertensive and atherosclerotic potential: Health benefits and recent advances.

  2024cited by this paper
• Quercetin ameliorates atherosclerosis by inhibiting inflammation of vascular endothelial cells via Piezo1 channels.

  2024cited by this paper
• Notoginsenoside R1 attenuates ischemic heart failure by modulating MDM2/β arrestin2-mediated β2-adrenergic receptor ubiquitination.

  2024cited by this paper
• Correction to: Colchicine's Role in Cardiovascular Disease Management.

  2024cited by this paper
• Global epidemiology of heart failure

  2024cited by this paper
• Research progress on pharmacological effects and bioavailability of berberine

  2024cited by this paper
• Cardiovascular Effects of Herbal Products and Their Interaction with Antihypertensive Drugs—Comprehensive Review

  2024cited by this paper
• Flavonoids: Potential therapeutic agents for cardiovascular disease

  2024cited by this paper
• Puerarin alleviates atherosclerosis via the inhibition of Prevotella copri and its trimethylamine production

  2024cited by this paper
• Berberine alleviates cholesterol and bile acid metabolism disorders induced by high cholesterol diet in mice.

  2024cited by this paper
• Isoliquiritigenin alleviates myocardial ischemia-reperfusion injury by regulating the Nrf2/HO-1/SLC7A11/GPX4 axis in mice.

  2024cited by this paper
• Berberine and health outcomes: An umbrella review

  2023cited by this paper
• Liensinine prevents ischemic injury following myocardial infarction via inhibition of Wnt/β‑catenin signaling activation.

  2023cited by this paper
• Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: Part 1. Physicochemical and pharmacokinetic properties

  2023cited by this paper
• Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: part 2. development of oral dosage formulations

  2023cited by this paper
• Phytobioactive compounds as therapeutic agents for human diseases: A review

  2023cited by this paper
• A Descriptive Review of the Action Mechanisms of Berberine, Quercetin and Silymarin on Insulin Resistance/Hyperinsulinemia and Cardiovascular Prevention

  2023cited by this paper
• The molecular mechanisms underlying anti‐inflammatory effects of galangin in different diseases

  2023cited by this paper
• Essential role of medicine and food homology in health and wellness

  2023cited by this paper
• Effects of Flavonoids on Cancer, Cardiovascular and Neurodegenerative Diseases: Role of NF-κB Signaling Pathway

  2023cited by this paper
• Rutin impedes human low-density lipoprotein from non-enzymatic glycation: A mechanistic insight against diabetes-related disorders.

  2023cited by this paper
• Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

  2023cited by this paper
• Integrated network pharmacology and molecular docking analyses of the mechanisms underlying the antihypertensive effects of lotusine.

  2023cited by this paper
• Dengzhan Shengmai capsule attenuates cardiac fibrosis in post-myocardial infarction rats by regulating LTBP2 and TGF-β1/Smad3 pathway.

  2023cited by this paper
• Microorganisms for Ginsenosides Biosynthesis: Recent Progress, Challenges, and Perspectives

  2023cited by this paper
• Beneficial effects of Panax notoginseng (Burkill) F. H. Chen flower saponins in rats with metabolic hypertension by inhibiting the activation of the renin–angiotensin–aldosterone system through complement 3

  2023cited by this paper
• Qili Qiangxin capsules for chronic heart failure: A GRADE-assessed clinical evidence and preclinical mechanism

  2023cited by this paper
• Berberine blocks inflammasome activation and alleviates diabetic cardiomyopathy via the miR‑18a‑3p/Gsdmd pathway.

  2023cited by this paper
• Astilbin protects from sepsis‐induced cardiac injury through the NRF2/HO‐1 and TLR4/NF‐κB pathway

  2023cited by this paper
• Efficacy and safety of oral Chinese patent medicines in the treatment of coronary heart disease combined with hyperlipidemia: a systematic review and network meta-analysis of 78 trials

  2023cited by this paper
• Qili Qiangxin (QLQX) capsule as a multi-functional traditional Chinese medicine in treating chronic heart failure (CHF): A review of ingredients, molecular, cellular, and pharmacological mechanisms

  2023cited by this paper
• Salvianolic acid A alleviates heart failure with preserved ejection fraction via regulating TLR/Myd88/TRAF/NF-κB and p38MAPK/CREB signaling pathways.

  2023cited by this paper
• Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial.

  2023cited by this paper
• Berberine alleviates myocardial diastolic dysfunction by modulating Drp1-mediated mitochondrial fission and Ca^2+ homeostasis in a murine model of HFpEF

  2023cited by this paper
• Research Progress of Flavonoids Regulating Endothelial Function

  2023cited by this paper
• Alkaloids as Vasodilator Agents: a Review.

  2023cited by this paper
• The protective roles of citrus flavonoids, naringenin, and naringin on endothelial cell dysfunction in diseases

  2023cited by this paper
• The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis

  2022cited by this paper
• Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib

  2022cited by this paper
• The effects of Ginsenosides on PI3K/AKT signaling pathway

  2022cited by this paper
• Rutin ameliorates inflammation and improves metabolic function: A comprehensive analysis of scientific literature.

  2022cited by this paper
• The Potential Use of Herbal Fingerprints by Means of HPLC and TLC for Characterization and Identification of Herbal Extracts and the Distinction of Latvian Native Medicinal Plants

  2022cited by this paper
• Luteolin attenuated cisplatin-induced cardiac dysfunction and oxidative stress via modulation of Keap1/Nrf2 signaling pathway

  2022cited by this paper
• Qili Qiangxin, a compound herbal medicine formula, alleviates hypoxia-reoxygenation-induced apoptotic and autophagic cell death via suppression of ROS/AMPK/mTOR pathway in vitro.

  2022cited by this paper
• Corynoline protects ang II-induced hypertensive heart failure by increasing PPARα and Inhibiting NF-κB pathway.

  2022cited by this paper
• Quercetin Mitigates Cisplatin-Induced Oxidative Damage and Apoptosis in Cardiomyocytes through Nrf2/HO-1 Signaling Pathway.

  2022cited by this paper
• Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota

  2022cited by this paper
• Saponins and their derivatives: potential candidates to alleviate anthracycline-induced cardiotoxicity and multidrug resistance.

  2022cited by this paper
• Epigallocatechin-3-gallate attenuates myocardial fibrosis in diabetic rats by activating autophagy

  2022cited by this paper
• Effect of puerarin supplementation on cardiovascular disease risk factors: A randomized, double-blind, placebo-controlled, 2-way crossover trial.

  2022cited by this paper
• Panaxatriol saponin ameliorates myocardial infarction-induced cardiac fibrosis by targeting Keap1/Nrf2 to regulate oxidative stress and inhibit cardiac-fibroblast activation and proliferation.

  2022cited by this paper
• The comparative effects of oral Chinese patent medicines combined with western medicine in stable angina: A systematic review and network meta-analysis of 179 trials

  2022cited by this paper
• Ginsenoside Rb3 upregulates sarcoplasmic reticulum Ca2+-ATPase expression and improves the contractility of cardiomyocytes by inhibiting the NF-κB pathway.

  2022cited by this paper
• Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research—The ConPhyMP—Guidelines

  2022cited by this paper

• No citing papers are available for this paper.